期刊文献+

阻塞性睡眠呼吸暂停低通气综合征对冠心病患者造影剂肾病发病率的影响 被引量:5

The Effect of Obstructive Seep Apnea Hypoventilation Syndrome on the Morbidity of Contrast-induced Nephropathy in Patients with Coronary Heart Disease
在线阅读 下载PDF
导出
摘要 目的探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)对冠心病(CHD)患者造影剂肾病(CIN)发病率的影响。方法根据冠状动脉造影及多导睡眠监测的结果,将研究对象分为CHD无OSAHS组48例、CHD并OSAHS组62例,比较两组冠状动脉造影前后血清肌酐的变化及造影剂肾病的发病率。结果两组血清肌酐水平在冠状动脉造影前48 h内差异无统计学意义(t=-0.733,P=0.465),冠状动脉造影和(或)经皮冠状动脉介入术后第1天、第3天CHD并OSAHS组血清肌酐水平高于CHD无OSAHS组,差异有统计学意义(t=-2.486,P=0.014;t=-2.921,P=0.004)。在纳入的研究对象中,18例发生CIN,总体CIN发生率为16.36%,其中CHD无OSAHS组4例,CIN发生率为8.33%,CHD并OSAHS组14例,CIN发生率为22.58%,两组患者CIN发病率差异具有统计学意义(χ2=4.013,P=0.045)。结论阻塞性睡眠呼吸暂停低通气综合征是冠心病患者造影剂肾病发生的一个相关风险因素。 Aim To investigate the effect of obstructive seep apnea hypoventilation syndrome (OSAHS) on the morbidity of contrast-induced nephropathy (CIN) in patients with coronary heart disease (CHD). Methods 110 pa- tients were divided into CHD without OSAHS group ( n = 48 ) and CHD with OSAHS group ( n = 62 ) according to diaognos- tic coronary angiography (CAG) and polysomnography (PSG). Before and after coronary angiography or percutaneous coronary intervention (PCI), the level of serum creatinine was compared between the two groups. The morbidity of CIN was compared between the two groups. Results The difference of the level of serum creatinine was not statistically significant between the two groups before coronary angiography (t = - 0. 733, P = 0. 465). The difference of the level of serum creatinine was statistically significant between the two groups after coronary angiography or percutaneous coronary in- tervention (t= -2.486, P=0.014; t= -2.921, P =0.004). The morbidity of CIN was higher in CHD with OSAHS group (X2 = 4. 013, P = 0. 045). Conclusion OSAHS is a risk factor of CIN in patients with CHD.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2014年第12期1255-1258,共4页 Chinese Journal of Arteriosclerosis
关键词 阻塞性睡眠呼吸暂停低通气综合征 冠心病 造影剂肾病 Obstructive Seep Apnea Hypoventilation Syndrome Coronary Heart Disease Contrast-induced Ne-phropathy
  • 相关文献

参考文献12

  • 1Badran M, Ayas N, Laher I. Insights into obstructive sleep apnea researeh[J]. Sleep Med, 2014, 15(5) : 485-495.
  • 2Kanbay A, Buyukoglan H, Ozdogan N, et al. Obstructive sleep ap- nea syndrome is related to the progression of chronic kidney disease [J]. Int Urol Nephrol, 2012, 44(2) : 535-539.
  • 3Bruno RM, Rossi L, Fabbrini M, et al. Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors [J]. J Hypertens, 2013, 31(7) : 1 456-464.
  • 4Nicholl DD, Hanly PJ, Poulin M J, et al. Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea[ J]. Am J Respir Crit Care Med, 2014, 190(5) 572-580.
  • 5Kinebuchi S, Kazama JJ, Satoh M, et al. Short term use of contin- uous positive airway pressure ameliorates glomerular hyperfihration in patients with obstructive sleep apnea syndrome [ J ]. Clin Sci (Lond), 2004, 107(3) : 317-322.
  • 6詹冰洁,钦光跃,郑艳文,张颖,陆晓玲.OSAHS患者早期肾功能变化及临床意义[J].医学研究杂志,2013,42(9):76-79. 被引量:8
  • 7Casserly LF, Chow N, Ali S, et al. Proteinuria in obstructive sleep apnea[J]. Kidney Int, 2001, 60(4) : 1 484-489.
  • 8Bing MH, Jennum P, Moiler LA, et al. Obstructive sleep apnea in a Danish population of men and women aged 60-80 years with noctu- ria[J]. J Clin Sleep Med, 2012, 8(5) : 515-520.
  • 9Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency [J]. Am J Kidney Dis, 2002, 39(5) : 930-936.
  • 10Evola S, Lunetta M, Macaione F, et al. Risk factors for contrast induced nephrupathy : a study among Italian patients [ J] . Indian Heart J, 2012, 64(5) : 484-491.

二级参考文献34

  • 1周力,陈晖,张侃,李虹伟.维生素C预防对比剂肾病的临床研究[J].心肺血管病杂志,2010,29(S1):88-88. 被引量:5
  • 2Solomon RJ,Mehran R, Natarajan MK, et al. Contrast induced nephropathy and long-term adverse events:Cause and effect. Clin J Am Soc Nephrol,2009, 4 : 1162-1169.
  • 3Liistro F, Falsini G, Bolognese L. The clinical burden of contrast media induced nephropathy. Ital Heart,2003,4:668-676.
  • 4Briguori C, Aimldi F, Morici N, et al. New Pharmacological proto- cols to prevent or reduce contrast-media nephropathy. Minerva C ardioa.ngiol, 2005,53 : 49 -58.
  • 5Bouzas-Mosquera A, Vaquez-Rodrfguez JM, Calvifio-Santos R, et al. Contrast-induced nephropathy and acute renal failure following emergent cardic catheterization : incidence, risk factors and prog- nosis. Rev Esp Cardiol,2007 ,60 :1026-1034.
  • 6Abe M, Kimura T, Mofimoto T, et al. Incidence of and risk fac- tors for contrast- induced nephropathy after cardiac catheter iza- tion in Japanese patients. Circ J,2009, 73:1518-1522.
  • 7McCullough PA, Adam A, Becker CR, et al. Epidemiology andprognostic implications of contrast-induced nephropathy. Am J Cardiol, 2006,98 : 5K-13K.
  • 8Chong E, Poh KK, Liang S, et al. Risk factorsand clinical out- comes for contrast-induced nephropathy after percmaneous coro- nary intervention in patients with normal serum creatinine. Ann Acad Med Singapore, 2010,39:374-380.
  • 9MueUer C, Buerkle G, Buetmer HJ, et al. Prevention of contrast rnediaassociated nephropathy:randomized companson of hydration regimenlS in 1620 patients undergoing coronary angioplasty. Arch Intern Med ,2002,162:329-336.
  • 10Nyman U, Bjork J, Aspelin P, et al. Contrast medium dose to GFR ratio:a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radi- o1,2008 ,49 :658-667.

共引文献23

同被引文献62

  • 1李琦.肺功能测定在外科中的应用[J].中国实用内科杂志,2013,33(S1):14-14. 被引量:2
  • 2刘洁,丁飞红,王琴,冯娜娜,刘子龙,朱芬,李善群,白春学,宋元林.肺功能对阻塞性睡眠呼吸暂停低通气综合征患者呼出气一氧化氮测定结果的影响[J].中国实用内科杂志,2013,33(S1):37-37. 被引量:2
  • 3党焱,李永春.阻塞性睡眠呼吸暂停低通气综合征的治疗进展[J].中国全科医学,2007,10(15):1296-1298. 被引量:11
  • 4Kapoor M, Greenough G. Home sleep tests for obstructive sleep apnea (OSA) [ J]. J Am BOard Fam Med,2015,28(4) :504-509.
  • 5Sforza E, Piehot V, Martin MS, et al. Prevalence and determinants of subjective sleepiness in healthy elderly with unrecognized obstructive sleep apnea[ J]. Sleep Med,2015,16(8) :981-986.
  • 6Bakirci EM, lnver E, Degirmenci H, et al. Serum YKL-40/chitinase 3- like protein 1 level is an Independent predictor of athemsclerosis devel- opment in patients with obstructive sleep apnea syndrome J ]. Turk Kardiyol Bern Ars,2015,43(4) :333-339.
  • 7Tung P, Zimetbaum P. Obstructive sleep apnea and atrial fibrillation progression. Another reason to wear continuous positive airway pressure? [J] AmHeartJ, 2015, 169 (5): 595-596.
  • 8Victor SM, Gnanaraj A, VijayaKumar S, et al. Risk scoring system to predict contrast induced nephrop- athy following percutaneous coronary intervention [J]. Indian Heart J, 2014, 66(5): 517 -524.
  • 9Sanei H, Hajian-Nejad A, Sajjadieh-Kajouei A, et al Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients under- going computed tomography angiography [ J ]. ARYA Atheroscler, 2014, 10(5) : 252 -258.
  • 10Sadat U, Usman A, Boyle JR, et al. Contrast me- dium-induced acute kidney injury [ J ]. Cardiorenal Med, 2015, 5(3) : 219 -228.

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部